• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝氨酸蛋白酶抑制剂 Kazal 型 1(SPINK1)促进接受同期放化疗的直肠癌患者的增殖、迁移、侵袭和辐射抵抗:精准医学的潜在靶点。

Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine.

机构信息

Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.

Department of Pathology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

Hum Cell. 2022 Nov;35(6):1912-1927. doi: 10.1007/s13577-022-00776-4. Epub 2022 Sep 2.

DOI:10.1007/s13577-022-00776-4
PMID:36053457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9515043/
Abstract

Serine peptidase inhibitor Kazal type-1 (SPINK1), a trypsin kinase inhibitor, is known to be associated with inflammation and pathogenesis. The aim in this study was to demonstrate the clinicopathological role and progression of SPINK1 in rectal cancer (RC) patients undergoing concurrent chemoradiotherapy (CCRT). Immunohistochemical staining for SPINK1 protein expression in 111 RC cases revealed high SPINK1 expression was significantly associated with perineural invasion and poor CCRT response in pre-CCRT specimens. In addition, multivariable analyses showed that pre-CCRT SPINK1 expression was a significant prognostic marker of both overall and disease-free survival in RC patients receiving pre-operative CCRT; furthermore, in vitro studies demonstrated SPINK1 interacted with EGFR to promote the abilities of proliferation, migration and invasion attenuated by SPINK1 si-RNA via ERK, p38, and JNK pathways. SPINK1 was also found to regulate radio-resistance in CRC cell lines. In conclusion, SPINK1 expression is an independent prognostic marker in patients receiving pre-operative CCRT, and SPINK1 regulates proliferation, migration and invasion via EGFR-downstream ERK, p38 and JNK pathways. The phenotypes of radiosensitivity that could be reversed with attenuation of SPINK1 levels suggest that targeting SPINK1 might offer a strategy for optimal precision medicine.

摘要

丝氨酸蛋白酶抑制剂 Kazal 型 1(SPINK1)是一种胰蛋白酶激酶抑制剂,已知与炎症和发病机制有关。本研究旨在证明 SPINK1 在接受同期放化疗(CCRT)的直肠癌(RC)患者中的临床病理作用和进展。对 111 例 RC 病例的 SPINK1 蛋白表达进行免疫组织化学染色显示,高 SPINK1 表达与神经周围侵犯和 CCRT 前标本反应不良显著相关。此外,多变量分析表明,在接受术前 CCRT 的 RC 患者中,CCRT 前 SPINK1 表达是总生存和无病生存的显著预后标志物;此外,体外研究表明,SPINK1 通过 ERK、p38 和 JNK 途径与 EGFR 相互作用,削弱了 SPINK1 si-RNA 的增殖、迁移和侵袭能力。还发现 SPINK1 调节 CRC 细胞系的放射抗性。总之,SPINK1 表达是接受术前 CCRT 的患者的独立预后标志物,SPINK1 通过 EGFR 下游的 ERK、p38 和 JNK 途径调节增殖、迁移和侵袭。SPINK1 水平降低可逆转的放射敏感性表型表明,针对 SPINK1 可能为最佳精准医学提供一种策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/c38a20d24984/13577_2022_776_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/3681e3781d72/13577_2022_776_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/efe44772f08e/13577_2022_776_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/2b1ffece5a71/13577_2022_776_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/b66c45e8f945/13577_2022_776_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/99d90e57c841/13577_2022_776_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/c38a20d24984/13577_2022_776_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/3681e3781d72/13577_2022_776_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/efe44772f08e/13577_2022_776_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/2b1ffece5a71/13577_2022_776_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/b66c45e8f945/13577_2022_776_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/99d90e57c841/13577_2022_776_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/327f/9515043/c38a20d24984/13577_2022_776_Fig6_HTML.jpg

相似文献

1
Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine.丝氨酸蛋白酶抑制剂 Kazal 型 1(SPINK1)促进接受同期放化疗的直肠癌患者的增殖、迁移、侵袭和辐射抵抗:精准医学的潜在靶点。
Hum Cell. 2022 Nov;35(6):1912-1927. doi: 10.1007/s13577-022-00776-4. Epub 2022 Sep 2.
2
Serine protease inhibitor Kazal type 1 (SPINK1) as a prognostic marker in stage IV colon cancer patients receiving cetuximab based targeted therapy.丝氨酸蛋白酶抑制剂Kazal型1(SPINK1)作为接受基于西妥昔单抗的靶向治疗的IV期结肠癌患者的预后标志物。
J Clin Pathol. 2016 Apr 22. doi: 10.1136/jclinpath-2016-203638.
3
Serine peptidase inhibitor Kazal type I (SPINK1) promotes BRL-3A cell proliferation via p38, ERK, and JNK pathways.丝氨酸蛋白酶抑制剂Kazal I型(SPINK1)通过p38、ERK和JNK信号通路促进BRL-3A细胞增殖。
Cell Biochem Funct. 2017 Aug;35(6):339-348. doi: 10.1002/cbf.3288.
4
High expression of serine protease inhibitor kazal type 1 predicts poor prognosis and promotes the progression and invasion of oral tongue squamous cell carcinoma.丝氨酸蛋白酶抑制剂 kazal 型 1 高表达预示着不良预后,并促进口腔舌鳞状细胞癌的进展和侵袭。
Arch Oral Biol. 2024 Aug;164:106003. doi: 10.1016/j.archoralbio.2024.106003. Epub 2024 May 17.
5
High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT.高 SPINK4 表达预示着接受 CCRT 的直肠癌患者预后不良。
Curr Oncol. 2021 Jun 25;28(4):2373-2384. doi: 10.3390/curroncol28040218.
6
MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E-mutant colorectal adenocarcinoma.MAPK 抑制剂诱导 BRAF V600E 突变型结直肠腺癌中丝氨酸蛋白酶抑制剂 Kazal 型 1(SPINK1)分泌。
Mol Oncol. 2018 Feb;12(2):224-238. doi: 10.1002/1878-0261.12160. Epub 2017 Dec 27.
7
Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.丝氨酸蛋白酶抑制剂Kazal 1型(SPINK1)通过表皮生长因子促进结直肠癌增殖作为一种预后标志物。
Pathol Oncol Res. 2015 Sep;21(4):1201-8. doi: 10.1007/s12253-015-9949-0. Epub 2015 Jun 3.
8
Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.丝氨酸蛋白酶抑制剂 Kazal 型 1,一种潜在的生物标志物,用于早期检测、靶向和预测肝细胞癌对免疫检查点阻断治疗的反应。
Front Immunol. 2022 Jul 18;13:923031. doi: 10.3389/fimmu.2022.923031. eCollection 2022.
9
Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway.丝氨酸蛋白酶抑制剂Kazal型1(SPINK1)通过MEK/ERK信号通路下调E-钙黏蛋白并诱导肝癌细胞发生上皮-间质转化,从而促进肝细胞癌转移。
J Dig Dis. 2017 Jun;18(6):349-358. doi: 10.1111/1751-2980.12486.
10
Identification and Exploration of Serine Peptidase Inhibitor Kazal Type I (SPINK1) as a Potential Biomarker Correlated with the Progression of Non-Small Cell Lung Cancer.丝氨酸蛋白酶抑制剂Kazal I型(SPINK1)作为与非小细胞肺癌进展相关的潜在生物标志物的鉴定与探索
Cell Biochem Biophys. 2022 Dec;80(4):807-818. doi: 10.1007/s12013-022-01098-w. Epub 2022 Oct 4.

引用本文的文献

1
Significance and mechanisms of perineural invasion in malignant tumors.恶性肿瘤中神经周围侵犯的意义及机制
Front Oncol. 2025 May 12;15:1572396. doi: 10.3389/fonc.2025.1572396. eCollection 2025.
2
SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma.SPINK1 诱导的肿瘤可塑性为肝癌的化疗提供了治疗窗口。
Nat Commun. 2023 Nov 29;14(1):7863. doi: 10.1038/s41467-023-43670-9.
3
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study.

本文引用的文献

1
Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma.针对自分泌 IL-6-SPINK1 信号轴抑制卵巢透明细胞癌的转移扩散。
Oncogene. 2020 Oct;39(42):6606-6618. doi: 10.1038/s41388-020-01451-4. Epub 2020 Sep 14.
2
miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling.miR-5089-5p 通过 miR-5089-5p/SPINK1/MAPK/MMP9 信号通路抑制去势抵抗性前列腺癌对恩扎卢胺的耐药性和转移。
Aging (Albany NY). 2020 Jul 21;12(14):14418-14433. doi: 10.18632/aging.103485.
3
Pancreatic secretory trypsin inhibitor reduces multi-organ injury caused by gut ischemia/reperfusion in mice.
丝裂原活化蛋白激酶11(p38β)通过控制电离辐射相关的衰老过程,成为细胞辐射敏感性的主要决定因素:一项体外研究。
Clin Transl Radiat Oncol. 2023 Jun 2;41:100649. doi: 10.1016/j.ctro.2023.100649. eCollection 2023 Jul.
4
A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer.一种用于预测II/III期结直肠癌术后复发的新型9基因标志物。
Front Genet. 2023 Jan 10;13:1097234. doi: 10.3389/fgene.2022.1097234. eCollection 2022.
胰腺分泌性胰蛋白酶抑制剂可减少小鼠肠缺血/再灌注引起的多器官损伤。
PLoS One. 2020 Jan 10;15(1):e0227059. doi: 10.1371/journal.pone.0227059. eCollection 2020.
4
Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.新辅助放化疗后局部进展期直肠癌的外科治疗。
Kaohsiung J Med Sci. 2020 Mar;36(3):152-159. doi: 10.1002/kjm2.12161. Epub 2019 Dec 9.
5
SPINK1 is a prognosis predicting factor of non-small cell lung cancer and regulates redox homeostasis.丝氨酸蛋白酶抑制剂Kazal型1是非小细胞肺癌的预后预测因子,并调节氧化还原稳态。
Oncol Lett. 2019 Dec;18(6):6899-6908. doi: 10.3892/ol.2019.11005. Epub 2019 Oct 18.
6
Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis.逐步发生的肝癌过程中基因组、表观基因组和转录组异常的动力学。
Cancer Res. 2019 Nov 1;79(21):5500-5512. doi: 10.1158/0008-5472.CAN-19-0991. Epub 2019 Sep 10.
7
Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer.表观遗传沉默的 miRNA-338-5p 和 miRNA-421 驱动 SPINK1 阳性前列腺癌。
Clin Cancer Res. 2019 May 1;25(9):2755-2768. doi: 10.1158/1078-0432.CCR-18-3230. Epub 2018 Dec 26.
8
SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker.丝氨酸蛋白酶抑制剂 Kazal 型 1(SPINK1)促进肺腺癌的细胞生长和转移,并作为一种新的预后生物标志物。
BMB Rep. 2018 Dec;51(12):648-653. doi: 10.5483/BMBRep.2018.51.12.205.
9
Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance.针对受损肿瘤微环境中的 SPINK1 可减轻治疗抵抗。
Nat Commun. 2018 Oct 17;9(1):4315. doi: 10.1038/s41467-018-06860-4.
10
Radiation-Induced Endothelial Vascular Injury: A Review of Possible Mechanisms.辐射诱导的内皮血管损伤:可能机制综述
JACC Basic Transl Sci. 2018 Aug 28;3(4):563-572. doi: 10.1016/j.jacbts.2018.01.014. eCollection 2018 Aug.